UAB Digital Repository of Documents 2 records found  Search took 0.02 seconds. 
1.
10 p, 554.6 KB Early Reduction of MRI Activity During 6 Months of Treatment With Cladribine Tablets for Highly Active Relapsing Multiple Sclerosis / De Stefano, Nicola (Hospital Universitari Vall d'Hebron) ; Barkhof, Frederik (Hospital Universitari Vall d'Hebron) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Achiron, Anat (Hospital Universitari Vall d'Hebron) ; Derfuss, Tobias (Hospital Universitari Vall d'Hebron) ; Chan, Andrew (Hospital Universitari Vall d'Hebron) ; Hodgkinson, Suzanne (Hospital Universitari Vall d'Hebron) ; Prat, Alexandre (Hospital Universitari Vall d'Hebron) ; Leocani, Letizia (Hospital Universitari Vall d'Hebron) ; Schmierer, Klaus (Hospital Universitari Vall d'Hebron) ; Sellebjerg, Finn (Hospital Universitari Vall d'Hebron) ; Vermersch, Patrick (Hospital Universitari Vall d'Hebron) ; Wiendl, Heinz (Hospital Universitari Vall d'Hebron) ; Keller, Birgit (Hospital Universitari Vall d'Hebron) ; Roy, Sanjeev (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
The onset of action for high-efficacy immunotherapies in multiple sclerosis (MS) is an important parameter. This study (MAGNIFY-MS) evaluates the onset of action of cladribine tablets by observing changes in combined unique active (CUA) MRI lesion counts during the first 6 months of treatment in patients with highly active relapsing MS. [...]
2022 - 10.1212/NXI.0000000000001187
Neurology® neuroimmunology & neuroinflammation, Vol. 9 (june 2022)  
2.
11 p, 760.7 KB Specific Patterns of Immune Cell Dynamics May Explain the Early Onset and Prolonged Efficacy of Cladribine Tablets / Wiendl, Heinz (Hospital Universitari Vall d'Hebron) ; Schmierer, Klaus (Hospital Universitari Vall d'Hebron) ; Hodgkinson, Suzanne (Hospital Universitari Vall d'Hebron) ; Derfuss, Tobias (Hospital Universitari Vall d'Hebron) ; Chan, Andrew (Hospital Universitari Vall d'Hebron) ; Sellebjerg, Finn (Hospital Universitari Vall d'Hebron) ; Achiron, Anat (Hospital Universitari Vall d'Hebron) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Prat, Alexandre (Hospital Universitari Vall d'Hebron) ; De Stefano, Nicola (Hospital Universitari Vall d'Hebron) ; Barkhof, Frederik (Hospital Universitari Vall d'Hebron) ; Leocani, Letizia (Hospital Universitari Vall d'Hebron) ; Vermersch, Patrick (Hospital Universitari Vall d'Hebron) ; Chudecka, Anita (Hospital Universitari Vall d'Hebron) ; Mwape, Claire (Hospital Universitari Vall d'Hebron) ; Holmberg, Kristina H. (Hospital Universitari Vall d'Hebron) ; Boschert, Ursula (Hospital Universitari Vall d'Hebron) ; Roy, Sanjeev (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
Cladribine tablets cause a reduction in lymphocytes with a predominant effect on B-cell and T-cell counts. The MAGNIFY-MS substudy reports the dynamic changes on multiple peripheral blood mononuclear cell (PBMC) subtypes and immunoglobulin (Ig) levels over 12 months after the first course of cladribine tablets in patients with highly active relapsing multiple sclerosis (MS). [...]
2022 - 10.1212/NXI.0000000000200048
Neurology® neuroimmunology & neuroinflammation, Vol. 10 (november 2022)  

See also: similar author names
5 Roy, S.
1 Roy, S. B.
1 Roy, Shyamali
1 Roy, Sneharika
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.